Skip to main content
Fig. 3 | Cancer Cell International

Fig. 3

From: Upregulated CD58 is associated with clinicopathological characteristics and poor prognosis of patients with pancreatic ductal adenocarcinoma

Fig. 3

The effect of CD58 in the prognosis of PDAC patients through analyzing different databases. a, b TIMER and OncoLnc platform demonstrated that high CD58 expression was an adverse prognostic factor for PDAC patients (p = 0.005 and 0.00135, respectively). c, d GEPIA showed that CD58 was not only significantly related to the OS of patients (p = 0.006), but also a negative factor for DFS in PDAC (p = 0.011). TPM transcripts per million. e, f Kaplan–Meier plotter online tool showed a similar result (p = 0.0013 and 0.022, respectively)

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us